Primary |
Thrombosis Prophylaxis |
36.7% |
Deep Vein Thrombosis |
10.2% |
Pulmonary Embolism |
7.7% |
Prophylaxis |
6.5% |
Atrial Fibrillation |
5.3% |
Ill-defined Disorder |
3.5% |
Supplementation Therapy |
3.2% |
Hypertension |
3.0% |
Embolism |
2.8% |
Anticoagulant Therapy |
2.7% |
Thrombosis |
2.3% |
Dialysis |
2.2% |
Acne |
2.0% |
Ear Infection |
2.0% |
Hypercoagulation |
2.0% |
Sepsis |
2.0% |
Pain |
1.8% |
Hallucination |
1.5% |
Essential Hypertension |
1.3% |
Myocardial Infarction |
1.3% |
|
Pulmonary Embolism |
30.9% |
Thrombocytopenia |
6.9% |
Thrombosis |
6.9% |
Death |
5.5% |
Medical Device Complication |
5.1% |
Deep Vein Thrombosis |
4.0% |
Platelet Count Increased |
4.0% |
Cerebral Infarction |
3.6% |
Drug Exposure During Pregnancy |
3.6% |
Drug Ineffective |
3.3% |
Phlebitis |
3.3% |
Heparin-induced Thrombocytopenia |
2.9% |
Gastrointestinal Haemorrhage |
2.5% |
Haematoma |
2.5% |
Oedema Peripheral |
2.5% |
Pulmonary Infarction |
2.5% |
Renal Impairment |
2.5% |
Suicide Attempt |
2.5% |
Thrombocythaemia |
2.5% |
Injury Associated With Device |
2.2% |
|
Secondary |
Drug Use For Unknown Indication |
26.7% |
Product Used For Unknown Indication |
19.5% |
Thrombosis Prophylaxis |
8.7% |
Prophylaxis |
5.2% |
Pain |
5.0% |
Deep Vein Thrombosis |
4.3% |
Infection Prophylaxis |
4.3% |
Hypertension |
3.4% |
Diarrhoea |
3.1% |
Nausea |
2.5% |
Pulmonary Embolism |
2.3% |
Atrial Fibrillation |
2.1% |
Sepsis |
2.1% |
Breast Cancer |
1.6% |
Malignant Melanoma |
1.6% |
Urinary Tract Infection |
1.6% |
Germ Cell Cancer |
1.5% |
Hallucination |
1.5% |
Pseudomonas Infection |
1.5% |
Anticoagulant Therapy |
1.4% |
|
Toxic Epidermal Necrolysis |
17.7% |
Liver Injury |
6.2% |
Pulmonary Embolism |
6.2% |
Vomiting |
6.2% |
White Blood Cell Count Decreased |
6.2% |
Thrombocytopenia |
5.4% |
Thrombosis |
5.4% |
Haematoma |
4.6% |
Phlebitis |
4.6% |
Rash |
4.6% |
Sepsis |
4.6% |
Stevens-johnson Syndrome |
4.6% |
Superinfection |
4.6% |
Urinary Tract Infection |
3.8% |
Contusion |
3.1% |
Haematuria |
3.1% |
Alanine Aminotransferase Increased |
2.3% |
Gastrointestinal Haemorrhage |
2.3% |
Pleural Effusion |
2.3% |
Pneumonia |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
25.3% |
Drug Use For Unknown Indication |
18.9% |
Prophylaxis |
9.6% |
Pain |
6.2% |
Hypertension |
5.4% |
Anticoagulant Therapy |
3.6% |
Multiple Myeloma |
3.3% |
Thrombosis Prophylaxis |
2.9% |
Infection |
2.9% |
Non-small Cell Lung Cancer |
2.7% |
Infection Prophylaxis |
2.4% |
Neoplasm Malignant |
2.2% |
Sedation |
2.1% |
Schizoaffective Disorder |
2.0% |
Fluid Replacement |
1.9% |
Diffuse Large B-cell Lymphoma |
1.9% |
Nausea |
1.8% |
Colorectal Cancer Metastatic |
1.7% |
Allogenic Bone Marrow Transplantation Therapy |
1.6% |
Constipation |
1.6% |
|
Deep Vein Thrombosis |
10.2% |
Vomiting |
9.6% |
Pulmonary Embolism |
8.2% |
Thrombocytopenia |
7.8% |
Sepsis |
6.2% |
White Blood Cell Count Decreased |
6.1% |
Pneumonia |
5.6% |
Pyrexia |
5.1% |
Renal Failure Acute |
4.5% |
Death |
4.3% |
Respiratory Failure |
4.3% |
Thrombosis |
4.2% |
Weight Decreased |
4.0% |
Urinary Tract Infection |
3.4% |
Renal Failure |
3.1% |
Septic Shock |
3.1% |
Tachycardia |
2.8% |
Premature Baby |
2.6% |
Rhabdomyolysis |
2.5% |
Drug Interaction |
2.2% |
|
Interacting |
Product Used For Unknown Indication |
22.5% |
Atrial Fibrillation |
10.8% |
Pneumonia Bacterial |
9.8% |
Psoriatic Arthropathy |
9.8% |
Thrombosis Prophylaxis |
6.9% |
Prophylaxis |
5.9% |
Back Disorder |
4.9% |
Acute Myocardial Infarction |
3.9% |
Deep Vein Thrombosis |
2.9% |
Depression |
2.9% |
Hip Arthroplasty |
2.9% |
Hypertension |
2.9% |
Lower Respiratory Tract Infection |
2.9% |
Pain |
2.9% |
Dyslipidaemia |
2.0% |
Rheumatoid Arthritis |
2.0% |
Diabetes Mellitus |
1.0% |
Folate Deficiency |
1.0% |
Hyperuricaemia |
1.0% |
Insomnia |
1.0% |
|
Blood Pressure Decreased |
20.0% |
Fall |
13.3% |
Gastrointestinal Inflammation |
13.3% |
Cytomegalovirus Test Positive |
6.7% |
Enterocolitis Haemorrhagic |
6.7% |
Haemorrhage |
6.7% |
Haemorrhoids |
6.7% |
Myocardial Infarction |
6.7% |
Occult Blood Positive |
6.7% |
Oesophagitis Ulcerative |
6.7% |
Wound Infection |
6.7% |
|